Skip to main content

Philips Recall Information

Important information regarding certain CPAPs, BiLevel PAPs, and ventilators (including non-invasive and invasive ventilation) manufactured by Philips Respironics. Please read the information below in detail.

Acknowledge the Recall Here

Resources

Download our Philips Respironics Recall Patient Brochure:

Download
PDF 4.2 MB

Read Philips Respironics CPAP Announcement:

Download
PDF 108.97 KB

Read Philips Respironics Ventilator Announcement:

Download
PDF 109.31 KB

Read the FAQ 


February 27, 2023

Please note we are updating the website posts and documents related to the Philips Respironics recall as we receive new information from Philips Respironics. All the website posts and documents are dated and updates within documents are clearly identified. 

Click here to check our  FAQ page for additional information.


Previous Updates


R2109 Recall

February 27, 2023 

On June 14, 2021, medical device manufacturer Philips Respironics issued a Field Safety Notice regarding the recall of several of its respiratory and ventilator device models currently on the market due to the health risks associated with their use. Full details of the recall are available on the Philips Respironics website: www.philips.ca/healthcare.

We realize that for many patients and clients, ensuring the continuity of treatment is crucial to their health and wellbeing. In contrast to Philip Respironics’ instructions to discontinue use of the affected devices, we recommend our patients do not discontinue their treatment without seeking advice from their physician first.

Most of the relevant learned medical associations for respiratory diseases, along with health authorities around the world recommend continuing treatment, regardless of the type of device and consulting your physician. The Canadian Sleep Society is recommending an individualized decision after discussion with the physician when an alternative device can’t be secured in a timely manner. For your safety, we recommend you seek medical advice regarding your treatment continuum. 

VitalAire Canada Inc. is dedicated to helping its patients and clients and will limit the inconveniences linked to the Philips Respironics device recall. Our team is closely monitoring the situation with Philips Respironics and will maintain continued communication with you as this situation evolves.

As part of our efforts to support our patients, we have registered with Philips Respironics, on behalf of our patients and clients, the serial numbers of all affected devices sold by VitalAire Canada Inc. to ensure these units are taken into consideration as part of the repair/replacement program under development. To prevent double registration, please do not go to the Philips Respironics website to register your device.

If your device is affected by the Philips recall, we require that you complete the Acknowledgment form to register your device and provide us with critical information to schedule the repair or replacement of your device.

If you purchased your device from us, you do not need to register your device through the Philips website.

Acknowledge Here

If you require assistance filling out this form, please contact us through this toll-free phone number 1-844-726-2727 available Monday to Friday from 9:00 to 16:00 Local time. Once we have further information from Philips Respironics on the repair/replacement program, we will contact you regarding the replacement or repair of your device and provide support throughout this process.

Best Regards

VitalAire Canada Inc.


JUNE 28, 2021

On June 14, 2021, medical device manufacturer Philips Respironics issued a Field Safety Notice regarding the recall of several of its respiratory and ventilator device models currently on the market due to the health risks associated with their use. Full details of the recall are available on the Philips Respironics website

We realize that for many patients and clients, ensuring the continuity of treatment is crucial to their health and wellbeing. Despite Philip Respironics’ instructions to the contrary, we recommend our patients not to discontinue their treatment without seeking advice from their physician first. 

Most of the relevant learned medical associations for respiratory diseases, along with health authorities around the world recommend continuing treatment, regardless of the type of device and consulting your physician. The Canadian Sleep Society is recommending an individualized decision after discussion with the physician when an alternative device can’t be secured in a timely manner.  For the sake of your safety, we recommend you seek medical advice regarding your treatment continuum.

VitalAire Canada Inc. is dedicated to helping its patients and clients and will limit the inconveniences linked to the Philips Respironics device recall. Our team is closely monitoring the situation with Philips Respironics and will maintain continued communication with you as this situation evolves.

On behalf of our patients and clients, we will register with Philips Respironics the serial numbers of all affected devices sold by VitalAire Canada Inc. to ensure they are taken into consideration as part of the repair/replacement program under development. 

Once we have further information from Philips Respironics on the repair/replacement program, we will be in touch regarding your device to ensure the appropriate settings of your new equipment and to assist you throughout this process. 

Meanwhile, for the most up-to-date information on this situation, please keep checking our website.  

Best regards.

VitalAire Canada Inc.

 

JUNE 17, 2021 

On June 14, 2021, medical device manufacturer Philips Respironics has issued a voluntary recall and safety notice for specific Phillips CPAP, BiLevel PAP and Ventilator Devices due to issues related to the polyester-based polyurethane (PE-PUR) sound abatement foam used in these devices. 

Patient safety is of utmost concern for VitalAire, we are fully mobilized to address the situation. As authorized distributors, we are actively discussing the issue with Philips Respironics and waiting to receive specific instructions from Phillips on the Philips Respironics repair/replacement program under development. For more information please review the announcement on the Philips Respironics website

We recommend you consult with your physician with any questions you may have regarding continuation of your therapy. We will be communicating with our patients as we receive more information and will update this website notice as Philips Respironics releases details regarding the repair/replacement process for its devices.

Best regards.

VitalAire Canada Inc.